ENDRA Life Sciences (NDRA) Short Interest Ratio & Short Volume $4.14 +0.03 (+0.73%) Closing price 04:00 PM EasternExtended Trading$4.14 0.00 (0.00%) As of 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock ENDRA Life Sciences Short Interest DataENDRA Life Sciences (NDRA) has a short interest of 130,100 shares, representing 17.29% of the float (the number of shares available for trading by the public). This marks a -44.12% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 62,845 shares to cover all short positions.Current Short Interest130,100 sharesPrevious Short Interest232,800 sharesChange Vs. Previous Month-44.12%Dollar Volume Sold Short$686.93 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares750,000 sharesFloat Size752,600 sharesShort Percent of Float17.29%Today's Trading Volume15,851 sharesAverage Trading Volume62,845 sharesToday's Volume Vs. Average25% Short Selling ENDRA Life Sciences? Sign up to receive the latest short interest report for ENDRA Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNDRA Short Interest Over TimeNDRA Days to Cover Over TimeNDRA Percentage of Float Shorted Over Time ENDRA Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025130,100 shares $686.93 thousand -44.1%17.3%0.1 $5.28 7/15/2025232,800 shares $1.88 million +1,373.4%30.9%0.1 $8.07 6/30/202515,800 shares $55.46 thousand -6.5%2.1%0 $3.51 6/15/202516,900 shares $58.31 thousand -67.1%2.3%0.1 $3.45 5/31/202551,400 shares $176.82 thousand -23.1%7.0%0.3 $3.44 5/15/202566,800 shares $214.43 thousand -45.2%9.1%0.4 $3.21 4/30/2025121,800 shares $732.02 thousand +172.5%21.7%0.8 $6.01 4/15/202544,700 shares $141.25 thousand +41.5%8.0%0.4 $3.16 3/31/202531,600 shares $127.98 thousand -22.2%5.6%1 $4.05 3/15/202540,600 shares $166.46 thousand +43.5%7.6%2.1 $4.10 Get the Latest News and Ratings for NDRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ENDRA Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 2/28/202528,300 shares $122.54 thousand -9.3%5.3%1.1 $4.33 2/15/202531,200 shares $156.47 thousand -6.0%5.8%0.7 $5.02 1/31/202533,200 shares $167.79 thousand -15.7%6.2%0.4 $5.05 1/15/202539,400 shares $236.40 thousand -24.5%7.3%0.2 $6.00 12/31/202452,200 shares $326.77 thousand +15.2%9.7%0.2 $6.26 12/15/202445,300 shares $193.43 thousand -32.3%8.4%0.2 $4.27 11/30/202466,900 shares $382.00 thousand +6.9%12.5%0.3 $5.71 11/15/202462,600 shares $284.20 thousand +160.8%11.7%0.2 $4.54 10/31/202424,000 shares $211.26 thousand -96.7%4.6%0.1 $8.80 10/15/2024717,700 shares $150.00 thousand +167.7%4.0%0.1 $0.21 9/30/2024268,100 shares $53.89 thousand +324.2%1.5%0.1 $0.20 9/15/202463,200 shares $14.54 thousand -65.7%0.4%0 $0.23 8/31/2024184,200 shares $70.49 thousand +11.7%1.0%0.1 $0.38 8/15/2024164,900 shares $21.44 million -24.5%11.4%0.1 $130.00 7/31/2024218,500 shares $17.15 thousand -5.9%N/A0 $0.08 7/15/2024232,100 shares $21.26 thousand -29.3%N/A0 $0.09 6/30/2024328,200 shares $31.87 thousand -75.0%N/A0 $0.10 6/15/20241,310,000 shares $135.72 thousand +371.9%N/A0.1 $0.10 5/31/2024277,600 shares $74.67 thousand +165.1%2.6%0 $0.27 5/15/2024104,700 shares $30.42 thousand +2,517.5%1.0%0.6 $0.29 4/30/20244,000 shares $1.13 thousand -47.4%0.0%0 $0.28 4/15/20247,600 shares $1.99 thousand -75.2%0.1%0 $0.26 3/31/202430,600 shares $17.75 thousand -36.9%0.3%0.2 $0.58 3/15/202448,500 shares $48.50 thousand -11.3%0.5%0.3 $1.00 2/29/202454,700 shares $61.26 thousand +86.1%0.5%0.4 $1.12 2/15/202429,400 shares $33.81 thousand +47.7%0.4%0.3 $1.15 1/31/202419,900 shares $20.90 thousand -73.7%0.2%0.2 $1.05 1/15/202475,700 shares $98.41 thousand -41.8%0.9%0.8 $1.30 12/31/2023130,000 shares $275.60 thousand -25.5%1.6%1.4 $2.12 12/15/2023174,500 shares $251.28 thousand -17.3%2.1%2.3 $1.44Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why (Ad)Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.Click here for the full story. 11/30/2023211,100 shares $206.43 thousand -11.8%2.6%1.9 $0.98 11/15/2023239,300 shares $227.34 thousand -6.1%2.9%2.4 $0.95 10/31/2023254,900 shares $251.08 thousand +56.5%3.5%2.2 $0.99 10/15/2023162,900 shares $169.42 thousand +28.9%2.2%1.4 $1.04 9/30/2023126,400 shares $140.32 thousand +175.4%1.7%1.1 $1.11 9/15/202345,900 shares $56.46 thousand -37.1%0.6%0.4 $1.23 8/31/202373,000 shares $85.41 thousand +5.5%1.0%1.2 $1.17 8/15/202369,200 shares $79.58 thousand +61.7%0.9%1.1 $1.15 7/31/202342,800 shares $53.07 thousand -20.0%0.6%0.8 $1.24 7/15/202353,500 shares $72.76 thousand -36.5%0.7%0.8 $1.36 6/30/202384,300 shares $118.02 thousand +13.2%1.2%1.3 $1.40 6/15/202374,500 shares $109.52 thousand +40.0%1.0%1.4 $1.47 5/31/202353,200 shares $78.20 thousand +54.7%0.8%1.2 $1.47 5/15/202334,400 shares $44.03 thousand -70.1%0.5%1 $1.28 4/30/2023114,900 shares $183.84 thousand +61.2%1.9%3.9 $1.60 4/15/202371,300 shares $131.91 thousand +124.2%2.4%5.7 $1.85 3/31/202331,800 shares $72.82 thousand -7.8%1.1%2.6 $2.29 3/15/202334,500 shares $124.20 thousand +24.1%1.2%2.6 $3.60 2/28/202327,800 shares $108.42 thousand -7.6%0.9%1.3 $3.90 2/15/202330,100 shares $111.37 thousand -9.1%1.0%1.4 $3.70 1/31/202333,100 shares $132.73 thousand -23.2%1.1%1.4 $4.01 1/15/202343,100 shares $202.57 thousand +28.3%1.4%1.8 $4.70 12/30/202233,600 shares $136.75 thousand -54.4%1.1%1.4 $4.07 12/15/202273,600 shares $374.62 thousand +173.6%2.4%3.2 $5.09 11/30/202226,900 shares $4.78 thousand -95.5%0.9%2 $0.18 11/15/2022597,800 shares $119.68 thousand +8.8%N/A2.2 $0.20 10/31/2022549,600 shares $126.41 thousand -19.7%N/A1.9 $0.23 10/15/2022684,800 shares $208.52 thousand -11.7%N/A2.1 $0.30 9/30/2022775,300 shares $237.24 thousand +0.1%N/A2.1 $0.31 9/15/2022774,500 shares $278.82 thousand +11.5%N/A1.9 $0.36 8/31/2022694,700 shares $202.64 thousand -8.8%N/A1.5 $0.29 8/15/2022761,900 shares $275.05 thousand +17.1%N/A1.3 $0.36 7/31/2022650,600 shares $178.78 thousand -6.2%N/A0.8 $0.27 7/15/2022693,400 shares $163.92 thousand -17.9%N/A0.6 $0.24 6/30/2022844,400 shares $196.75 thousand +97.2%N/A0.3 $0.23 6/15/2022428,200 shares $102.77 thousand -55.0%N/A0.1 $0.24 5/31/2022952,400 shares $219.05 thousand +282.3%N/A0.3 $0.23 5/15/2022249,100 shares $49.57 thousand -86.9%N/A0.1 $0.20 4/30/20221,900,000 shares $492.86 thousand -12.0%N/A0.8 $0.26 4/15/20222,160,000 shares $559.44 thousand +285.8%N/A0.9 $0.26 3/31/2022559,900 shares $218.36 thousand +30.2%N/A0.4 $0.39 3/15/2022430,200 shares $167.78 thousand +32.1%1.1%1.6 $0.39 2/28/2022325,600 shares $139.36 thousand -11.2%0.8%1.2 $0.43 2/15/2022366,500 shares $160.89 thousand +16.8%0.9%1.2 $0.44 1/31/2022313,900 shares $188.34 thousand -38.4%0.8%1 $0.60 1/15/2022509,300 shares $352.94 thousand -1.4%1.2%1.6 $0.69 12/31/2021516,400 shares $357.25 thousand +5.2%1.3%1.7 $0.69 12/15/2021491,000 shares $374.14 thousand -11.9%1.2%1.8 $0.76 11/30/2021557,200 shares $530.51 thousand -45.4%1.4%2.2 $0.95 11/15/20211,020,000 shares $1.36 million -15.0%2.5%4 $1.33Capital Gains Tax Strategies for Seniors (Ad)Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure. SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation.Click here to see the three strategies and get matched with a financial advisor today. 10/29/20211,200,000 shares $1.90 million +9.1%2.9%4.4 $1.58 10/15/20211,100,000 shares $1.74 million -10.6%2.7%4.2 $1.58 9/30/20211,230,000 shares $2.13 million +0.8%3.0%4.2 $1.73 9/15/20211,220,000 shares $2.12 million +1.7%3.0%3.5 $1.74 8/31/20211,200,000 shares $2.28 million +53.4%2.9%3.1 $1.90 8/13/2021782,100 shares $1.27 million -27.6%1.9%1.9 $1.62 7/30/20211,080,000 shares $1.94 million +30.6%2.7%2.5 $1.80 7/15/2021827,100 shares $1.55 million +7.9%2.0%1.5 $1.87 6/30/2021766,800 shares $1.67 million -4.1%1.9%1.2 $2.18 6/15/2021799,200 shares $1.71 million +28.2%2.0%1 $2.14 5/28/2021623,400 shares $1.32 million -46.3%1.5%0.6 $2.12 5/14/20211,160,000 shares $2.30 million -10.8%N/A0.8 $1.98 4/30/20211,300,000 shares $3.21 million -3.7%N/A0.7 $2.47 4/15/20211,350,000 shares $3.08 million +13.5%N/A0.6 $2.28 3/31/20211,190,000 shares $3.06 million +304.4%N/A0.4 $2.57 3/15/2021294,300 shares $735.75 thousand -34.1%N/A0.1 $2.50 2/26/2021446,800 shares $1.10 million +19.6%N/A0.2 $2.46 2/12/2021373,700 shares $852.04 thousand -61.8%N/A0.1 $2.28 1/29/2021979,400 shares $1.97 million +98.2%N/A0.4 $2.01 1/15/2021494,200 shares $499.14 thousand +3.6%N/A0.3 $1.01 12/31/2020476,900 shares $355.29 thousand -11.2%N/A0.9 $0.75 12/15/2020537,300 shares $482.93 thousand -2.2%N/A1.7 $0.90 11/30/2020549,600 shares $467.43 thousand +5.1%N/A3.2 $0.85 11/15/2020522,900 shares $441.33 thousand -12.7%N/A3.7 $0.84 10/30/2020598,900 shares $430.07 thousand +3.5%N/A4 $0.72 10/15/2020578,800 shares $421.66 thousand +0.2%N/A2.6 $0.73 9/30/2020577,800 shares $422.66 thousand -1.9%N/A1.9 $0.73 9/15/2020588,800 shares $471.04 thousand -1.2%N/A1.4 $0.80 8/31/2020595,700 shares $488.47 thousand -2.6%N/A1.2 $0.82 NDRA Short Interest - Frequently Asked Questions What is ENDRA Life Sciences' current short interest? Short interest is the volume of ENDRA Life Sciences shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 130,100 shares of NDRA short. 17.29% of ENDRA Life Sciences' shares are currently sold short. Learn More on ENDRA Life Sciences' current short interest. What is a good short interest percentage for ENDRA Life Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 17.29% of ENDRA Life Sciences' floating shares are currently sold short. Is ENDRA Life Sciences' short interest increasing or decreasing? ENDRA Life Sciences saw a decrease in short interest in the month of July. As of July 31st, there was short interest totaling 130,100 shares, a decrease of 44.1% from the previous total of 232,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ENDRA Life Sciences' float size? ENDRA Life Sciences currently has issued a total of 750,000 shares. Some of ENDRA Life Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ENDRA Life Sciences currently has a public float of 752,600 shares. How does ENDRA Life Sciences' short interest compare to its competitors? 17.29% of ENDRA Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to ENDRA Life Sciences: Nexalin Technology, Inc. (0.17%), Tenon Medical, Inc. (1.29%), Meihua International Medical Technologies Co., Ltd. (0.23%), Beyond Air, Inc. (10.43%), Lyra Therapeutics, Inc. (2.95%), DIH Holding US, Inc. (4.32%), Intelligent Bio Solutions Inc. (7.34%), Co-Diagnostics, Inc. (1.94%), Innovative Eyewear, Inc. (7.52%), Predictive Oncology Inc. (1.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short ENDRA Life Sciences stock? Short selling NDRA is an investing strategy that aims to generate trading profit from ENDRA Life Sciences as its price is falling. NDRA shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ENDRA Life Sciences? A short squeeze for ENDRA Life Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NDRA, which in turn drives the price of the stock up even further. How often is ENDRA Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NDRA, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies NXL Short Interest TNON Short Interest MHUA Short Interest XAIR Short Interest LYRA Short Interest DHAI Short Interest INBS Short Interest CODX Short Interest LUCY Short Interest POAI Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NDRA) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENDRA Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ENDRA Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access